https://www.selleckchem.com/pr....oducts/elimusertib-b
In the multivariate analysis, 6MWD was an independent predictor for survival (p = 0.002) and WHO-FC for TTCW (p = 0.001). In patients with PAH and comorbidities these parameters had no significant association with survival and TTCW. Average risk score was significantly associated with survival (p = 0.001) and TTCW (p = 0.013) in PAH but not in PAH with comorbidities (both p 0.05; figure 1). Conclusion Risk stratification based on ESC/ERS-guidelines could only be confirmed in patients without comorbidities, but not
Like
Comment
Share
